Publicly Traded Cannabis Stock News

Why Cannabis Investors Prefer Canada

Perhaps the biggest story of 2016 in the cannabis capital markets was the surge in prices and the amount of capital raised for the cannabis industry in Canada during...
- December 26th, 2016 at 1:30 pm

CanniMed Therapeutics (TSX: CMED) Prices IPO at $12

CanniMed Therapeutics (TSX: CMED) priced its initial public offering at $12, selling 5mm shares through a syndicate led by AltaCorp Capital to raise $60mm. The underwriters, which also included Canaccord...
- December 21st, 2016 at 6:57 pm

Canopy Health Innovations Names Marc Wayne President

Canopy Health Innovations Closes Financing & Announces Leadership Appointment SMITHS FALLS, ON, Dec. 21, 2016 /CNW/ – Canopy Growth Corporation (TSX:CGC) (OTC: TWMJF) (“Canopy Growth” or “CGC”) is pleased...
- December 21st, 2016 at 3:22 pm

Emblem Cannabis Oil Production Approved by Health Canada

Emblem Corp. Gets Green Light from Health Canada to Begin Production of Cannabis Oils PARIS, ONTARIO, Dec 19, 2016 (Marketwired via COMTEX) — PARIS, ONTARIO–(Marketwired – Dec 19, 2016)...
- December 19th, 2016 at 9:00 am

Canadian Cannabis Producer Maricann to Trade Publicly

Danbel Ventures Inc. and Maricann Inc. Announce Letter Agreement Relating to Reverse Takeover Transaction and Closing of Financing TORONTO, ONTARIO, Dec 15, 2016 (Marketwired via COMTEX) — TORONTO, ONTARIO–(Marketwired...
- December 15th, 2016 at 7:34 pm

Cannabis Software Provider Whaxy to Merge with MassRoots

MassRoots Enters into Definitive Agreement to Acquire Whaxy in Cash and Stock Deal DENVER, Dec. 15, 2016 /PRNewswire/ — MassRoots, Inc. (OTC: MSRT), one of the leading technology platforms...
- December 15th, 2016 at 4:37 pm

Canopy Growth Statement on Cannabis Task Force Report

SMITHS FALLS, ON, Dec. 13, 2016 /CNW/ – After a preliminary review of the findings of the special Task Force which today released recommendations on the regulation of recreational...
- December 13th, 2016 at 3:11 pm

OrganiGram Reports FY16 Sales of $6.1mm

OrganiGram Reports Financial Results and Summary Update MONCTON, NEW BRUNSWICK–(Marketwired – Dec. 13, 2016) – OrganiGram Holdings Inc. (TSXV: OGI) (OTC: OGRMF) (the “Company”) announced the financial results for...
- December 13th, 2016 at 9:26 am

Emblem to Begin Trading on the TSX Venture

Emblem Corp. Goes Public under Symbol EMC.V TORONTO, ONTARIO–(Marketwired – Dec. 8, 2016) – After much anticipation from the North American investment community, Emblem Corp. (TSXV: EMC) is set...
- December 8th, 2016 at 3:02 pm

Aurora Cannabis CEO Projects Profitability at Hand

Aurora Cannabis (TSXV: ACB) (OTC: ACBFF) CEO Terry Booth was interviewed Friday by Andrew Bell of BNN, who began with a question about the company’s financials.  Booth stated that...
- December 6th, 2016 at 7:39 pm

iAnthus Acquires Assets of Organix in Breckenridge, Colorado

iAnthus Closes Its First Cannabis-Related Asset Acquisition in Colorado TORONTO, ON and NEW YORK, NY — (Marketwired) — 12/05/16 — iAnthus Capital Holdings, Inc., (CSE: IAN) (OTC: ITHUF) (“Company”), announced...
- December 5th, 2016 at 9:29 pm

GW Pharma Ends FY16 with $483mm in Cash

GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress – Three Positive Phase 3 Epidiolex clinical trials reported in 2016 – – NDA submission...
- December 5th, 2016 at 7:52 am

GW Pharma Progresses Towards Epidiolex FDA Submission

GW Announces New Epidiolex® (CBD) Positive Phase 3 Data in Dravet Syndrome and Lennox-Gastaut Syndrome – Posters Presented at American Epilepsy Society Annual Meeting – – New data includes...
- December 5th, 2016 at 7:39 am